Rigel Pharmaceuticals Inc 10-K for FY2021
Rigel Pharmaceuticals Inc (RIGL)
10-K
2022-03-01
For: 2021-12-31
View Original
Added on
April 06, 2026
About this 10-K
Rigel Pharmaceuticals Inc filed this 10-K on March 1, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $149.24M
- up 37.4% from $108.62M a year earlier
- Net loss
- $17.91M
- compared with a net loss of $29.74M a year earlier
- Diluted EPS
- -$0.11
- compared with -$0.18 a year earlier